Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old
- People who have gastric cancer that has spread to the lining of the abdomen (peritoneum), confirmed by tissue or fluid testing during surgical exploration
- People whose cancer spread to the abdominal lining is limited (classified as P1 or P2 according to a specific gastric cancer staging system)
- People with liver spread where the largest affected area measures 5 cm or smaller
- People with certain lymph node spread in the area around the major abdominal blood vessel (the aorta), in a specific region between two named points, where the affected lymph nodes are at least 1 cm in size
- People who have ovarian tumours caused by the spread of gastric cancer (called Krukenberg tumours), in one or both ovaries — this counts as one site of spread
- People who have spread to no more than two sites in the body
- People who are in good general health and able to carry out daily activities without limitation (confirmed with trial site)
- People whose blood test results show the bone marrow, liver, and kidneys are working well enough to safely participate
- People whose expected survival is greater than 3 months
- People who are able to receive nutrition through a feeding tube and have the mental capacity to give informed consent
- People who have already completed 4 cycles of standard first-line systemic (whole-body) treatment for their cancer
- People for whom a repeat keyhole (laparoscopic) procedure after first-line treatment has shown that surgery to remove the cancer appears feasible
- People whose scans show no cancer spread to areas outside the abdomen (such as the lungs or bones)
- People whose scans show the abdominal lining disease has not grown or spread further since starting treatment
- People with a specific cancer spread score (called PCI) below 12
- People where only cancer cells in fluid are found, without visible spread on the abdominal lining, may still be considered
- People for whom surgeons believe there is a reasonable chance of removing all visible cancer with clear edges (called R0 resection)
- People for whom an appropriate level of lymph node removal during surgery is considered feasible
Who may not be able to join:
- People who have or develop cancer spread to areas outside the abdomen (such as lungs or bones) at any point
- People who have had another cancer diagnosed in the last 5 years, except for a specific type of non-melanoma skin cancer (basal cell carcinoma) or very early-stage cervical changes
- People of reproductive age who are not willing to use adequate contraception during the trial
- People with significant other health conditions that, in the opinion of the trial doctor, would make participation unsafe or unsuitable
- People with uncontrolled ongoing or active infections, heart failure, unstable chest pain, or irregular heart rhythm
- People with mental health conditions or personal circumstances that would make it difficult to follow the trial requirements
- People who are pregnant or breastfeeding
- People who have previously had surgery to remove part of the stomach for gastric cancer
- People whose cancer got worse — either on scans or based on symptoms — while receiving first-line treatment (including worsening fluid build-up in the abdomen that required medical procedures, or caused significant symptoms)
- People whose cancer is judged to be too extensive to remove safely, including those with a PCI score above 12, large sections of bowel involved, cancer in certain parts of the pancreas or bile ducts, cancer in a specific area near the liver called the hepatoduodenal ligament, cancer wrapped around major blood vessels, or cancer spread into the food pipe (oesophagus) in a way that makes complete removal unlikely
- People who choose to withdraw from the study at any time
- People for whom the trial doctor decides it is in their best interest to stop participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +84918133915
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Median survival time; Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.